Cite

HARVARD Citation

    Shapiro, S. et al. (2021). Survival and drug persistence in patients receiving inhaled treprostinil at doses greater than 54 µg (nine breaths) four times daily. Pulmonary circulation. pp. 1-7. [Online]. 
  
Back to record